Read Full Article
BOSTON & SYDNEY--(Business Wire)--GI Dynamics, Inc. (ASX:GID), a medical device company that has commercialized EndoBarrier ® in Europe, the ...
Dr. Cohen and Dr. Thompson will be valued members of the GI Dynamics SAB.
GI Dynamics with EndoBarrier has produced an excellent adjuvant tool to achieve diabetes control.
EndoBarrier is an exciting and novel technology that fills a rapidly expanding treatment gap in the management of type 2 diabetes and obesity. The GI Dynamics team has pioneered the advancement of our understanding of disease and treatment mechanisms over the past decade, and this device holds tremendous promise.